1159. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has conducted any mapping exercise since 2020 identifying which publicly funded health-related bodies are subject to the Code of Practice for the Governance of State Bodies, the Charities Governance Code, service-level agreements, or alternative governance frameworks; and if so, to provide details. [38921/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions under the heading Health Services.
2,701 questions match, newest first.
1160. Deputy Ken O'Flynn asked the Minister for Health whether any publicly funded health-sector bodies classified by the Central Statistics Office as public bodies are legally independent companies limited by guarantee; the number identified; and the aggregate level of State funding provided to such bodies in each year since 2020. [38922/26]
1161. Deputy Ken O'Flynn asked the Minister for Health whether the Department has conducted any governance risk assessment regarding publicly funded bodies that are legally independent of the State but depend primarily on Exchequer funding; and if so, to provide details. [38923/26]
1223. Deputy Ken O'Flynn asked the Minister for Health if the HSE has assessed the clinical impact of reimbursement delays for patients with progressive neurological conditions where irreversible deterioration may occur during the assessment process. [39068/26]
1224. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains any target timeframe for completion of reimbursement assessments relating to treatments for progressive neurodegenerative diseases. [39069/26]
1252. Deputy Ken O'Flynn asked the Minister for Health whether any audit, review, or expenditure-control process has examined referral concentration patterns, repeat provider usage, or high-cost treatment clustering under the treatment abroad scheme since 2020. [39145/26]
1288. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any assessment of the long-term financial impact of increasing reliance on the treatment abroad scheme for procedures not currently available in Ireland. [39190/26]
1290. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records clinical outcomes, complication rates or patient satisfaction data in respect of procedures funded under the treatment abroad scheme. [39192/26]
1293. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has conducted any audit specifically examining value-for-money, expenditure controls or financial governance under the treatment abroad scheme since 2020. [39195/26]
1294. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains data comparing the cost of treatments funded abroad under the treatment abroad scheme against estimated equivalent domestic treatment costs. [39196/26]
1297. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any central register of adverse clinical outcomes, complications, revision procedures, hospital readmissions or patient safety incidents arising from treatments funded under the treatment abroad scheme.; and if she will make a statement on the matter. [39199/26]
1298. Deputy Ken O'Flynn asked the Minister for Health whether the HSE receives any routine post-treatment clinical outcome reports from overseas providers in respect of procedures funded under the treatment abroad scheme. [39200/26]
1300. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has carried out any review of long-term patient outcomes associated with procedures funded under the treatment abroad scheme since 2020. [39202/26]
1304. Deputy Ken O'Flynn asked the Minister for Health the number of complaints, adverse incident reports, legal claims or clinical governance concerns associated with procedures funded under the treatment abroad scheme since 2020. [39206/26]
1305. Deputy Ken O'Flynn asked the Minister for Health whether the Department has sought legal advice regarding governance and duty-of-care obligations arising from State-funded overseas medical procedures where no structured outcomes monitoring system exists. [39207/26]
1310. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has ever examined category-specific overseas treatment expenditure under the treatment abroad scheme; and if so, to provide details. [39213/26]
1312. Deputy Ken O'Flynn asked the Minister for Health whether any national clinical governance framework exists governing referrals for overseas gender affirmation surgeries funded through the treatment abroad scheme. [39215/26]
1314. Deputy Ken O'Flynn asked the Minister for Health whether any post-treatment outcome monitoring or follow-up governance arrangements exist for persons funded for overseas gender affirmation surgeries under the treatment abroad scheme. [39217/26]
1315. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has undertaken any national capacity assessment of the public pre-exposure prophylaxis (PrEP) programme since 2024; and if so, if she will provide details of the findings, including identified service gaps, unmet demand, regional pressures and recommended expansion measures. [39272/26]
1316. Deputy Ken O'Flynn asked the Minister for Health the number of persons currently awaiting access to public PrEP services, by clinic and by HSE health region; and whether this figure includes informal, paused or closed waiting lists. [39273/26]
1317. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any centralised record of persons unable to access public PrEP services due to capacity constraints; and if not, whether she considers the absence of such data to represent a governance or public health oversight issue. [39274/26]
1318. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment has been undertaken regarding individuals sourcing PrEP medication privately from overseas due to inability to access the public system; and if she will provide details of any such assessment. [39275/26]
1321. Deputy Ken O'Flynn asked the Minister for Health how many public PrEP clinics nationally are currently closed, fully or partially, to new self-referrals; the duration of each restriction; and the reasons cited for same. [39278/26]
1322. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has considered establishing a temporary national bridging pathway or interim prescribing arrangement for persons unable to access public PrEP services due to capacity limitations. [39279/26]
1323. Deputy Ken O'Flynn asked the Minister for Health the number of approved private or GP PrEP providers currently operating nationally and by county; and whether the HSE has assessed the financial impact on patients required to access private consultations and testing due to lack of public capacity. [39280/26]